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INTRODUCTION
After the inhalation anesthesia, the renal function 
depends on the systemic hemodynamics, renal blood 
ϐlow, distribution of the renal blood ϐlow and tubular 
sensitivity to ϐluoride (Fish, 1994). The objective 
quantiϐication of the renal function impairment 
degree is difϐicult - there are many factors causing 
such manifestation. Many anesthesia practices and 
surgical procedures, like antibiotics, surgical stress, 
preexistent renal diseases, intraoperative blood 
pressure, site of intervention and anesthetics were 
incriminated in causing renal disfunction, but none 
has been evaluated in prospective studies (Ebert and 
Arain, 2000). 
The nephrotoxicity of some anesthetic pro-
ducts has been assessed in some reports. Sahin et al. 
(2011) observed an increase in the postoperative 
values of the blood urea nitrogen, creatinin and 
glycosuria in comparison with the preoperative 
ones in sevoϐlurane group, but without any 
signiϐicant differences compared with the control 
group.They suspected that these discrete changes 
of the renal function are due to the surgical stress. 
Eger et al. (1997) reported the fact that when the 
volunteers were administered sevoϐlurane for 2-4 
hours, the markers of renal injury did not modify 2 
hours after the anesthesia, but a slight albuminuria 
and increased α glutation-s-transferase (GST) 
were recorded. Based on these results, they claim 
that the threshold for renal lesions in humans is 
between 80 and 160 ppm-h Compound A. On the 
contrary, other authors have found that under the 
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Abstract
Various researchers studied the nephrotoxicity of inhalational anesthetics, with contradictory results. 
We aimed to observe the impact of the repeated isoϐlurane or sevoϐlurane anesthesia on kidney structure and 
function. 40 female rats were used in this study. Animals were divided in 8 groups. Two groups served as control: 
IM (isoϐlurane) and SM (sevoϐlurane), exposed to oxygen alone (1l/min) 3 times, for 2 hours, every other day. 
Three groups were anesthetized with isoϐlurane (I1, I2, I3) and the other three (S1, S2, S3) with sevoϐlurane. 
The anesthetics were administered three times, for two hours long each, every other day. Rats were sacriϐiced 
through cervical dislocation as follows: groups IM, SM, I1, S1 imediately after the last anesthesia, groups I2, S2 – 
6 hours post-anesthesia and groups I3, S3 – 24 hours post-anesthesia. Kidney samples were harvested, ϐixed in 
10% buffered formaline, embedded in parafϐin, sectioned (5 μm thickness) and stained with Goldner’s trichrome 
metod. After isoϐlurane anesthesia, the kidney displays a moderate congestion in the corticomedullary area, which 
maintains throughout the experimental period. The only changes in animals anesthetized with sevoϐlurane also 
appear on the vascular component. The congestion maintains throughout the experimental period in the renal 
cortex, as well as the corticomedullary area. No other aspects that suggest functional impairment are observed, 
in any of the experimental groups. Inhalational anesthesia with isoϐlurane and sevoϐlurane produces a moderate 
congestion, without majorly impairing the kidney function.
Keywords: congestion, isoϔlurane, kidney, sevoϔlurane.
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same experimental conditions, neither 4, nor 8 
hours of sevoϐlurane anesthesia have signiϐicantly 
affected the kidney functionality (Ebert et 
al., 1998a; 1998b). There were studies which 
evaluated the effects of prolonged anesthesia 
with low-ϐlow sevoϐlurane on kidney function, by 
comparing high-ϐlow sevoϐlurane anesthesia with 
low-ϐlow isoϐlurane anesthesia. The renal function 
was assessed through uremia, serum creatinine, 
creatinine clearance and urinary excretion of 
glucose, albumine, protein and N-acetil-β-D-
glucosaminidase. Uremia and serum creatinine 
were in normal range and creatinine clearance did 
not decrease during the study in none of the groups. 
Instead, the urinary glucose excretion, albumine, 
protein and N-acetil-β-D-glucosaminidase have 
increased after anesthesia in all groups, but no 
signiϐicant differences between groups were 
noticed at any moment. Lactate dehydrogenase 
and alkaline phosphatase were higher after high-
ϐlow sevoϐlurane anesthesia. The conclusion of 
this experiment was that prolonged anesthesia 
with low-ϐlow sevoϐlurane has the same effects on 
renal funcions as high-ϐlow sevoϐlurane and low-
ϐlow isoϐlurane anesthesia. (Obata et al., 2000)
Karasch et al. (2001) did not observe 
signiϐicant differences between sevoϐlurane 
and isoϐlurane renal effects in surgical patients, 
undergoing prolonged low-ϐlow anesthesia (for 
up to 17 hours). They determined the serum 
creatinine and blood urea nitrogen levels, the 
creatinine or urine protein and glucose excretion 
clearance. Although there were certain increases 
in the postoperatory values of serum creatinine, 
blood urea nitrogen and glycosuria levels, they 
were still situated within normal limits. Repeated 
exposure to sevoϐlurane and isoϐlurane between 
30 and 180 days did not have an additional risk 
of increasing the urinary protein and glucose 
excretion in comparison with the ϐirst exposure 
to the same anesthetic (Nishiyama et al., 1998). 
Some authors have reached the conclusion that 
there is no evidence of nephrotoxic effects of 
sevoϐlurane in mice and rats, by studying the 
effects of sevoϐlurane anesthesia on these animals 
(Frink et al., 1992; Malan et al., 1993).
The aim of our study was to investigate any 
possible renal injures following exposure of rats 
to inhalation anesthetic products (isoϐlurane and 
sevoϐlurane).
MATERIAL AND METHODS
Animals in this experimental study were 
ϐirst acclimatized to the new conditions: 22-230C, 
around 60% humidity and a 12 hour light/dark 
cycle. The rats beneϐited of an ad libitum rodent 
pelleted diet (Cantacuzino Institute, Romania) 
and also water. The study was conducted in 
accordance with the European Union legislation 
on animal experimentation and with the practices 
of the Romanian Board of Animal Research. We 
also obtained the approval from the Committee 
of Animal Ethics at Faculty of Veterinary Medicine 
Cluj-Napoca, Romania.
The experimental protocol was carried out 
at the Discipline of Anesthesiology and Surgical 
Propedeutics at the University of Agricultural 
Sciences and Veterinary Medicine.
40 female Wistar rats (6 weeks old) were used 
in the experimental study. The rats were divided 
into 8 groups, each group consisting of 5 rats. Two 
groups served as control: IM (isoϐlurane control 
group) and SM (sevoϐlurane control group). 
The two control groups were exposed to oxygen 
alone (1l/min) 3 times, for 2 hours, with a 2 day 
interval between exposures. Three groups (I1, I2 
and I3) were subdued to isoϐlurane anesthesia 
(isoϐlurane concentration = 1.5 %), and the other 
three (S1, S2 and S3) to sevoϐlurane anesthesia 
(sevoϐlurane concentration = 2%). The anesthetic 
administration was made in 3 rounds, 2 hours each, 
at a 2 day interval between the administrations. 
The oxygen supply throughout the anesthesia 
was 1l O
2
/min in both isoϐlurane and sevoϐlurane 
anesthesias. 
The rats were sacriϐiced through cervical 
dislocation as follows: groups IM, SM, I1 and S1 
immediately after the last anesthesia, groups 
I2 and S2 – 6 hours post-anesthesia, and groups 
I3 and S3 – 24 hours post-anesthesia. Kidney 
samples were harvested and ϐixed  in 10% buffered 
formaline, embedded in parafϐin, sectioned at a 5 
μm thickness and stained with Goldner’s trichrome 
method. 
RESULTS AND DISCUSSIONS
Rat kidneys from control groups have a normal 
aspect in both renal cortex (Fig. 1) and medulla. 
Bowman’s space, as well as the uriniferous tubules 
have normal sizes and do not contain a speciϐic 
material that would suggest the impairment of the 
glomerular ultraϐiltration process. 
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sense that the only changes appear on the vascular 
component. At the completion of the anesthesia, 
the congestion is present in the cortical zone on 
both small and large caliber vessels, with the 
highest intensity in the corticomedullary zone. 
The congestion maintains throughout the whole 
experimental period in the renal cortex (Fig. 3), 
as well as the passage zone between cortex and 
medulla (Fig. 4). 
At the completion of the isoϐlurane anesthesia, 
the kidney does not present notable changes in 
comparison with the control group, the only aspect 
that is worth taking into account is the moderate 
congestion of the vessels in the corticomedullary 
zone (Fig. 2). This congestion maintains throug-
hout the whole experimental period, with a slight 
increase at 6 and 24 hours post-anesthesia.
In the case of the sevoϐlurane anesthetized 
animals, the situation is highly comparable, in the 
Impact of Isoϐlurane and Sevoϐlurane Anesthesia on Kidney Structure and Function in Rats
Fig. 1. Control group – Renal cortex (10X obj. Goldner’s trichrome stain)
Fig. 2. Isoϐlurane group – Congestion in the corticomedullary zone 
(10X obj. Goldner’s trichrome stain)
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At the end of the isoϐlurane anesthesia, the 
kidney widely maintains a comparable aspect to the 
kidney of the rats in the control group, regarding 
the urine ϐiltration components, conditioning and 
transport. There are no materials in neither the 
urinary space of Bowman’s capsule, nor the lumen 
of uriniferous tubules to suggest the impairment 
of the urine ϐiltration, reabsorbtion, concentration 
or transport processes. The only aspect that could 
result after the anesthetic action was observed on 
the vascular component and is represented by a 
relatively discrete congestion, with a more distinct 
expression in small vessels in the corticomedullary 
zone. We mention that they are not at a high 
intensity and are not accompanied by functional 
changes associated with vascular permeability 
(not even discrete). We observed no oedemas or 
other aspects that might appear in such a situation. 
After anesthesia, the congestion maintains in 
the same area (corticomedullary), slightly and 
Fig. 3. Sevoϐlurane group – Renal cortex (40X obj. Goldner’s trichrome stain)
Fig. 4. Sevoϐlurane group – Corticomedullary zone 
(10X obj. Goldner’s trichrome stain)
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progressively increasing in intensity at 6 and 24 
hours, respectively. This aspect suggests that the 
anesthetic determines a discrete increase in the 
renal blood ϐlow, but does not rich such an extent 
as to signiϐicantly impair the organ functionality, 
at least not in the species taken into study and at 
the administered dose. 
The kidneys from rats anesthetized with sevo-
ϐlurane also display changes only in the vascu-
lar component: a vascular ectasia present on 
both large and small vessels in the renal cortex, 
with the largest intensity on small vessels in 
the corticomedullary zone. The intensity of the 
congestion is a bit more pronounced than the 
one in rats anesthetized with isoϐlurane. The 
congestion is largely maintained throughout the 
experiment, but its intensity does not increase. 
Also, in the case of sevoϐlurane anesthesia there 
are no aspects to suggest kidney structure or 
functionality impairing. 
The presence and persistence of the congestion 
in the areas that contain components participating 
in urine ϐiltration and conditioning, highlight the 
increase in renal blood ϐlow after sevoϐlurane 
administration. This aspect could inϐluence the 
glomerular ϐiltration processes to a certain extent, 
namely unwinding them at a slightly higher 
intensity, but without exceeding the physiologic 
limits. This aspect could be interpreted as an effort 
of the organism to eliminate the anesthetic in the 
shortest time possible, which we consider to be 
beneϐic for the body.
Studying the potential toxic effect of repeated 
exposure to sevoϐlurane, Elena et al. (2003) 
observed a signiϐicant increase of the relative 
weight of the kidney, but without any other aspects 
that would betray the existence of functional 
impairment of the kidney, and histological studies 
did not reveal the existence of lesions detectable 
through light microscopy. Other authors have 
reported the increase of the relative weight of the 
kidneys after sevoϐlurane anesthesia (Basketter 
et al., 1995), without noticing histopathological 
impairments or differences in renal function, 
assessed through relevant pathophysiologic 
markers, like plasma urea and creatinine 
concentrations. They did not manage to ϐind an 
explanation to show a potential causal link for 
the increased kidney weigh in treated animals. 
Analyzing these results, we observe that they 
deserve a bit of attention, because it is not enough 
to notice the increase in kidney weight, without 
trying to ϐind a logical explanation. In our opinion, 
there could be only one explanation, namely, an 
increased blood supply to the kidney under the 
inϐluence of the anesthetic, which modiϐies the 
organ weight, directly proportional to the excess 
blood (in comparison to the usual situation) 
existent at a given time. The increased blood ϐlow 
does not necessarily produce structural changes 
and does not majorly impair the glomerular 
ϐiltration processes, but eventually intensiϐies 
them to a certain extent. In our opinion, it is 
the only plausible explanation for the aspect 
reported by the forementioned authors, even 
if these authors did not notice it. Moreover, the 
investigation conducted by us, clearly highlights 
this aspect, because we did not observe structural 
changes in the renal components either, but we 
observed the existence of a relatively persistent 
congestion, present in the animals that underwent 
sevoϐlurane anesthesia. It is true that we did not 
weigh the kidneys, but indirectly we can state that 
the increased blood ϐlow determines a certain 
increase of the organ weight. As long as it does 
not majorly impair kidney functionality, it can not 
be considered to be a negative aspect, especially 
considering that this increased blood ϐlow is 
transient.
The explanation concerning the vasodilatation 
(at the corticomedullary junction) remains obscure 
for us, but it is known that the intrarenal blood 
ϐlow is redistributed towards the inner cortex and 
medulla following ischemia or hypoperfusion. 
It occurs because the vasoconstrictive effects of 
angiotensin II. Accordingly, perfusion of outer 
cortical nephrons is reduced while the perfusion 
of inner cortical nephrons is maintained (Jubb 
et al., 1985). Regarding our study, it is likely that 
during anesthesia, an impaired oxigenation of the 
blood may occur that may trigger the described 
reaction in the kidney parenchyma. 
CONCLUSION
The nephrotoxic effects of some anesthetic 
products have been assessed in some reports, 
but only a limited number of them used the 
histological assessment. Inhalational anaesthesia 
with isoϐlurane and sevoϐlurane didn’t induce 
major histological changes in the kidney 
parenchyma except for a moderate vasodilatation 
at the corticomedullary junction.
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